Cargando…
Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509512/ https://www.ncbi.nlm.nih.gov/pubmed/32651250 http://dx.doi.org/10.1136/jnnp-2020-323457 |
_version_ | 1783585612285083648 |
---|---|
author | Binks, Sophie Irani, Sarosh R |
author_facet | Binks, Sophie Irani, Sarosh R |
author_sort | Binks, Sophie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7509512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-75095122020-10-05 Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology Binks, Sophie Irani, Sarosh R J Neurol Neurosurg Psychiatry Editorial Commentary BMJ Publishing Group 2020-10 2020-07-10 /pmc/articles/PMC7509512/ /pubmed/32651250 http://dx.doi.org/10.1136/jnnp-2020-323457 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Editorial Commentary Binks, Sophie Irani, Sarosh R Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology |
title | Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology |
title_full | Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology |
title_fullStr | Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology |
title_full_unstemmed | Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology |
title_short | Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology |
title_sort | combining clinical and molecular heterogeneity within caspr2-antibody mediated diseases: towards the underlying disease biology |
topic | Editorial Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509512/ https://www.ncbi.nlm.nih.gov/pubmed/32651250 http://dx.doi.org/10.1136/jnnp-2020-323457 |
work_keys_str_mv | AT binkssophie combiningclinicalandmolecularheterogeneitywithincaspr2antibodymediateddiseasestowardstheunderlyingdiseasebiology AT iranisaroshr combiningclinicalandmolecularheterogeneitywithincaspr2antibodymediateddiseasestowardstheunderlyingdiseasebiology |